{"transactions":[{"id":1984608,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":22963,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":45927,"derivative":{"underlying":"Common Stock","underlying_shares":22963},"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":1984607,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":5286,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":5287,"derivative":{"underlying":"Common Stock","underlying_shares":5286},"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":1984606,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":14833,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14833},"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":1984605,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":11813,"price":2.17,"value":25634.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":53136,"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":1984604,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":22963,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":64949,"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":1984603,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":5286,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":41986,"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":1984602,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-01T21:55:29.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":14833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36700,"source":{"system":"sec-edgar","filing":"0001127602-23-007932","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223007932/form4.xml","form_type":"4"}},{"id":2020610,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-13T22:04:25.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":280100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":280100,"derivative":{"exercise_price":2.43,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":280100},"source":{"system":"sec-edgar","filing":"0001127602-23-004944","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223004944/form4.xml","form_type":"4"}},{"id":2020609,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-13T22:04:25.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":93370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":93370,"derivative":{"underlying":"Common Stock","underlying_shares":93370},"source":{"system":"sec-edgar","filing":"0001127602-23-004944","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223004944/form4.xml","form_type":"4"}},{"id":2369721,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":5287,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":10573,"derivative":{"underlying":"Common Stock","underlying_shares":5287},"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2369720,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":14834,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":14833,"derivative":{"underlying":"Common Stock","underlying_shares":14834},"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2369719,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":10007,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10007},"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2369718,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":8261,"price":2.85,"value":23543.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto."}],"balance_after":21867,"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2369717,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":5287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":30128,"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2369716,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":14834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":24841,"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2369715,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-01T00:17:06.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":10007,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10007,"source":{"system":"sec-edgar","filing":"0001127602-22-007175","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222007175/form4.xml","form_type":"4"}},{"id":2398988,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-14T21:09:30.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":68890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant."}],"balance_after":68890,"derivative":{"underlying":"Common Stock","underlying_shares":68890},"source":{"system":"sec-edgar","filing":"0001127602-22-004765","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222004765/form4.xml","form_type":"4"}},{"id":2398987,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":116259,"kind":"person","name":"Seth Kiernan","position":1,"cik":"0001890439","reported_name":"Seth Kiernan","relationship":{"officer":true,"officer_title":"VP, Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-14T21:09:30.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":206670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter."}],"balance_after":206670,"derivative":{"exercise_price":3.2,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":206670},"source":{"system":"sec-edgar","filing":"0001127602-22-004765","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222004765/form4.xml","form_type":"4"}}]}